Immunogen, Inc. (IMGN) Tops Q1 EPS by 10c, Guides FY Higher
Immunogen, Inc. (NASDAQ: IMGN) reported Q1 EPS of ($0.13), $0.10 better than the analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)